Literature DB >> 15888106

Prostaglandin E2 (PGE2) downregulates interleukin (IL)-1alpha-induced IL-6 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells.

K Noguchi1, M Maeda, S M P M Ruwanpura, I Ishikawa.   

Abstract

OBJECTIVES: Prostaglandin E2 (PGE2) exerts its biological actions via EP receptors, which are divided into four subtypes, EP1, EP2, EP3 and EP4. In the present study, we examined whether PGE2 regulated interleukin (IL)-1alpha-induced IL-6 production in human periodontal ligament (PDL) cells and if so, which subtypes of PGE2 receptors were involved.
METHODS: PDL cells were stimulated with vehicle or IL-1alpha in the presence or absence of indomethacin (a cylooxygenase inhibitor), PGE2 or various EP agonists. IL-6 and PGE2 levels were measured by enzyme-linked immunosorbent assay. EP receptor mRNA expression was examined by reverse transcription-polymerase chain reaction (RT-PCR).
RESULTS: Indomethacin significantly enhanced IL-1alpha-induced IL-6 production by PDL cells, although it completely inhibited IL-1alpha-induced PGE2 production. Exogenous PGE2 significantly suppressed IL-1alpha-induced IL-6 production. Butaprost, a selective EP2 agonist, and ONO-AE1-329, a selective EP4 agonist, significantly inhibited IL-1alpha-induced IL-6 production, although 17-phenyl-omega-trinor PGE2, an EP1 agonist, and ONO-AP-324, an EP3 agonist, did not affect it. RT-PCR analysis showed that EP2 and EP4 mRNA was expressed in PDL cells.
CONCLUSIONS: We suggest that PGE2 downregulates IL-1alpha-induced IL-6 production via EP2/EP4 receptors in human PDL cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888106     DOI: 10.1111/j.1601-0825.2005.01059.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  5 in total

1.  Influence of acetaminophen and ibuprofen on in vivo patellar tendon adaptations to knee extensor resistance exercise in older adults.

Authors:  C C Carroll; J M Dickinson; J K LeMoine; J M Haus; E M Weinheimer; C J Hollon; P Aagaard; S P Magnusson; T A Trappe
Journal:  J Appl Physiol (1985)       Date:  2011-05-19

2.  Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain.

Authors:  Xiao-Min Wang; Tian-Xia Wu; May Hamza; Edward S Ramsay; Sharon M Wahl; Raymond A Dionne
Journal:  Pain       Date:  2006-10-27       Impact factor: 6.961

Review 3.  Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.

Authors:  May Hamza; Raymond A Dionne
Journal:  Curr Mol Pharmacol       Date:  2009-01       Impact factor: 3.339

4.  Prostaglandin E2 differentially modulates proinflammatory/prodestructive effects of TNF-alpha on synovial fibroblasts via specific E prostanoid receptors/cAMP.

Authors:  Elke Kunisch; Anne Jansen; Fumiaki Kojima; Ivonne Löffler; Mohit Kapoor; Shinichi Kawai; Ignacio Rubio; Leslie J Crofford; Raimund W Kinne
Journal:  J Immunol       Date:  2009-06-19       Impact factor: 5.422

5.  Prostaglandin E2 receptor type 2-selective agonist prevents the degeneration of articular cartilage in rabbit knees with traumatic instability.

Authors:  Hiroto Mitsui; Tomoki Aoyama; Moritoshi Furu; Kinya Ito; Yonghui Jin; Takayuki Maruyama; Toshiya Kanaji; Shinsei Fujimura; Hikaru Sugihara; Akio Nishiura; Takanobu Otsuka; Takashi Nakamura; Junya Toguchida
Journal:  Arthritis Res Ther       Date:  2011-09-14       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.